News
A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical ...
The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid ...
Cedars-Sinai investigators have discovered a signaling interaction between two proteins in cells that controls fat ...
Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.
Results of the study, conducted in partnership with Xi'an Jiaotong University Health Science Center, are published in Signal Transduction and Targeted Therapy. "Atherosclerosis and vascular ...
News Medical on MSN18d
New bioactive compound for difficult-to-treat allergiesIrritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...
Professors Yuxiang Sun and Shaodong Guo were honored as 2025 Chancellor Enhancing Development and Generating Excellence in Scholarship Fellows ...
Molecular Plant-Microbe Interactions (MPMI), the leading journal for research on plant-pathogen interactions, is pleased to announce the publication ...
News Medical on MSN19d
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammalsA drug candidate previously successful at treating severe fatty liver disease, reduces atherosclerosis in large mammals, a study suggests. The compound, DT-109, presents as a dual-action drug capable ...
The study findings have been published in the journal Signal Transduction and Targeted Therapy. If you have ever been bitten by a mosquito, you will know how annoying the resulting itching can be.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results